MYIA
NEUE

Mount Yale Investment Advisors’s NeueHealth NEUE Stock Holding History

Mount Yale Investment Advisors’s Portfolio NEUE Stock Details NEUE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-32
Closed -$221 – 1641
2025
Q2 		$221 Buy
+32
New +$215 ﹤0.01% 1451

Other funds holding NEUE

NMC
NEA Management Company Timonium, Maryland $1.59B AUM 234.06% 1-Year Est. Return
DMC
Deer Management Company Larchmont, New York $812M AUM 2.64% 1-Year Est. Return
SG
StepStone Group La Jolla, California $2.16B AUM 20.11% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
RM
Redpoint Management Woodside, California $204M AUM 31.92% 1-Year Est. Return
G
Greycroft New York $44.1M AUM 24.2% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
PGH
Partners Group Holding Baar-Zug, Switzerland $1.47B AUM 8.59% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Blackstone Inc
Blackstone Inc New York $32.9B AUM 23.66% 1-Year Est. Return

Mount Yale Investment Advisors's NEUE Position: Q3 2025 in Review

Mount Yale Investment Advisors sold out of NeueHealth (NEUE) in Q3 2025, closing a stake of 32 shares — an estimated $221 sold.

Mount Yale Investment Advisors first reported a position in NEUE in Q2 2025 and held it in 1 quarter. The position peaked at $221 in Q2 2025. 38 funds tracked by Wall St. Rank hold NEUE as of Q3 2025.

  • Mount Yale Investment Advisors reported no remaining NeueHealth position as of Q3 2025 after selling out during the quarter.
  • Mount Yale Investment Advisors sold 32 NeueHealth shares in Q3 2025, an estimated $221.
  • Mount Yale Investment Advisors first reported a position in NeueHealth in Q2 2025 and held it in 1 quarter.
  • Mount Yale Investment Advisors's NeueHealth position peaked at $221 in Q2 2025.
  • 38 funds tracked by Wall St. Rank held NeueHealth as of Q3 2025.

Based on Mount Yale Investment Advisors's 13F filing for Q3 2025, filed 14 Nov 2025.